BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1390347)

  • 1. Radiation therapy: a long term cost benefit analysis in a North American region.
    Glazebrook GA
    Clin Oncol (R Coll Radiol); 1992 Sep; 4(5):302-5. PubMed ID: 1390347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy: are we getting value for money?
    Barton MB; Gebski V; Manderson C; Langlands AO
    Clin Oncol (R Coll Radiol); 1995; 7(5):287-92. PubMed ID: 8580053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit in radiation therapy: long-term survival and cost of treatment.
    Stevens G; Firth I
    Australas Radiol; 1997 Feb; 41(1):29-34. PubMed ID: 9125063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the benefit and cost of radiotherapy for lung cancer.
    Barbera L; Walker H; Foroudi F; Tyldesley S; Mackillop W
    Int J Technol Assess Health Care; 2004; 20(4):545-51. PubMed ID: 15609808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved management of radiotherapy departments through accurate cost data.
    Kesteloot K; Lievens Y; van der Schueren E
    Radiother Oncol; 2000 Jun; 55(3):251-62. PubMed ID: 10869740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.
    Vegter S; Tolley K; Keith MS; Lok CE; Soroka SD; Morton AR
    Clin Ther; 2012 Jul; 34(7):1531-43. PubMed ID: 22742885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the cost-effectiveness of postmastectomy radiation therapy.
    Marks LB; Hardenbergh PH; Winer ET; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):91-8. PubMed ID: 10219800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness studies in radiation therapy.
    Sher DJ
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation Oncology.
    Scott MT; Todd KE; Oakley H; Bradley JA; Rotondo RL; Morris CG; Klein S; Mendenhall NP; Indelicato DJ
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):401-405. PubMed ID: 27475669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Roadmap and Cost Implications of Establishing Comprehensive Cancer Care Using a Teleradiotherapy Network in a Group of Sub-Saharan African Countries With No Access to Radiation Therapy.
    Datta NR; Heuser M; Bodis S
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1334-1343. PubMed ID: 27315665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the cost of radiotherapy for 5-year local control and overall survival benefit.
    Batumalai V; Wong K; Shafiq J; Hanna TP; Gabriel G; Heberle J; Koprivic I; Kaadan N; King O; Tran T; Cassapi L; Forstner D; Delaney GP; Barton M
    Radiother Oncol; 2019 Jul; 136():154-160. PubMed ID: 31015119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of linear accelerators.
    Graham MV
    Rays; 1999; 24(3):373-8. PubMed ID: 10605297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THe cost of radiotherapy. Piedmontese experience].
    Gabriele P; Ozzello F; Negri GL; Rotta P; Pasquino M; Sinistrero G
    Radiol Med; 1998 Jun; 95(6):656-62. PubMed ID: 9717551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cost-Effectiveness Analysis of Teleglaucoma Screening Device.
    Thomas S; Hodge W; Malvankar-Mehta M
    PLoS One; 2015; 10(9):e0137913. PubMed ID: 26382956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. They're measuring the quality of patient care.
    Powers WE
    Am Med News; 1979 Apr; 22(17):suppl 4-5. PubMed ID: 10308881
    [No Abstract]   [Full Text] [Related]  

  • 20. Costs of radiotherapy.
    Norlund A;
    Acta Oncol; 2003; 42(5-6):411-5. PubMed ID: 14596503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.